GBLX - GB Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20193/31/20183/31/20173/31/2016
Total Revenue3,454.5522,510.364--
Cost of Revenue3,246.097782.727--
Gross Profit208.4551,727.637--
Operating Expenses
Research Development----
Selling General and Administrative15,802.78319,552.2888,933.1116,958.769
Non Recurring----
Others----
Total Operating Expenses19,048.8820,335.0158,933.1116,958.769
Operating Income or Loss-15,594.328-17,824.651-8,933.111-6,958.769
Income from Continuing Operations
Total Other Income/Expenses Net-8,559.814-5,334.574-1,149.992-120.209
Earnings Before Interest and Taxes-15,594.328-17,824.651-8,933.111-6,958.769
Interest Expense-5,191.259-5,176.361-901.134-105.204
Income Before Tax-24,154.142-23,159.225-10,083.103-7,078.978
Income Tax Expense526.145---
Minority Interest8,855.7572,882.9977.421-78.603
Net Income From Continuing Ops-24,680.287-23,159.225-10,083.103-7,078.978
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-23,653.165-22,974.19-9,909.83-6,771.335
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-26,514.601-22,974.19-9,909.83-6,771.335